content: <html>
  <head>
       <title></title>
  </head>
  <BODY STYLE="font-size: 10pt">
  
  <p style="margin: 0"><B>&nbsp;</B></P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B></B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>UNITED STATES</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>FORM 8-K</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>CURRENT REPORT</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>Pursuant to Section 13 or 15(d) of the Securities
  Exchange Act of 1934</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center">Date of Report (Date of earliest event reported):
  December 30, 2016</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>GREENESTONE HEALTHCARE CORPORATION</B></P>
  
  <P STYLE="margin: 0; text-align: center">(Exact name of registrant as specified in its
  charter)</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Colorado</B></FONT></TD>
      <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>000-15078</B></FONT></TD>
      <TD STYLE="width: 35%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>84-1227328</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                           or other jurisdiction of</FONT></P>
          <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation
          or organization)</FONT></P></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission
      File Number)</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
                                           Employer</FONT></P>
          <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
          No.)</FONT></P></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5734
                                           Yonge Street, Suite 300</B></FONT></P>
          <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>North
          York, Ontario, Canada M2M 4E7</B></FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
      of principal executive offices)</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 100%; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(416)
      222-5501</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&rsquo;s
      telephone number, including area code)</FONT></TD></TR>
  </TABLE>
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">Check the appropriate box below if the Form
  8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 3%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
      ]</FONT></TD>
      <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="margin: 0; text-align: justify; width: 96%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
      communications pursuant to Rule 425 under the Securities Act</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 3%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
      ]</FONT></TD>
      <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="margin: 0; text-align: justify; width: 96%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
      material pursuant to Rule 14a-12 under the Exchange Act</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 3%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
      ]</FONT></TD>
      <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="margin: 0; text-align: justify; width: 96%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
      communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 3%; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
      ]</FONT></TD>
      <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="margin: 0; text-align: justify; width: 96%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
      communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: left">&nbsp;</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>
  
  <!-- Field: Page; Sequence: 1 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"></P><P STYLE="margin-top: 0; margin-bottom: 0"></P></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B></B></P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B></B></P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B></B></P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>
  
  <P STYLE="margin: 0; text-align: justify"><B>Item 1.01</B><FONT STYLE="background-color: white">&nbsp;</FONT><B>Entry
  into a Material Definitive Agreement.</B></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>Item
  1.01</B>&nbsp;<B>Entry into a Material Definitive Agreement.</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">On
  December 19, 2016 GreeneStone Healthcare Corporation, a Colorado corporation (the &ldquo;Company&rdquo;) closed on a private offering
  (the &ldquo;Private Offering&rdquo;) to raise USD$500,000.00 in capital. Pursuant to the Private Offering, the Company entered
  into convertible note agreements (the &quot;Series L Convertible Notes&quot; or the &quot;Notes&quot;) in exchange for advances
  to the Company of $469,000.00 in total, with certain accredited investors (each an &ldquo;Investor,&rdquo; and collectively the
  &ldquo;Investors&rdquo;) and a warrant agreement (the &ldquo;Warrant Agreement&rdquo;) equal to one Warrant for each dollar of
  Convertible Note issued.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">The
  Convertible Notes and Warrants issued by the Company raised an aggregate principal amount of USD$469,000.00, as follows: (i) the
  Company issued eight Notes for a total of USD$469,000.00 convertible at the option of the Investors into 15,633,333 shares the
  Company&rsquo;s common stock (the &ldquo;Common Stock&rdquo;), par value USD$0.01; and (ii) the Company issued 15,633,333 Warrants.
  Unless otherwise provided for in the Notes, the Notes bear a 0% interest rate and mature six months from the date of issuance.
  At any time during the term of each of the Notes, each of the Investors may elect to convert the amount owed under a Note to shares
  of Common Stock of the Company, at a conversion price of USD$0.03 per share of Common Stock. The Warrants entitle each Warrant
  holder to purchase a single share of the Company&rsquo;s Common Stock at an exercise price of USD$0.03 per share for each Warrant
  exercised. The Warrants expire on December 18, 2019. </FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">The
  Notes and the Warrants were offered and sold without registration under the Securities Act of 1933, as amended (the &ldquo;Securities
  Act&rdquo;), in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act, as provided in Rule 506 of Regulation
  D promulgated thereunder. The Warrants and the Notes, and the Common Stock issuable upon exercise of the Warrants and conversion
  of the Notes, have not been registered under the Securities Act, or any other applicable securities laws, and unless so registered
  may not be offered or sold in the United States, except pursuant to an exemption from the registration requirements of the Securities
  Act.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">$249,444.44
  of the proceeds raised in the Private Offering has been used to repay in full certain indebtedness of the Company to JMJ Financial.
  The Company plans to use the balance of the proceeds for its operations.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">The
  foregoing description of the Series L Convertible Notes, Warrant Agreements and the Warrants does not purport to be complete and
  is qualified in its entirety by reference to the forms of the Warrant Agreement (including the form of the Warrant and the Warrant
  exercise form) and the Notes, copies of which are attached hereto as Exhibit 10.1 and Exhibit 10.2 and incorporated herein by
  reference.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>Item
  2.03</B>&nbsp;<B>Creation of a Direct Financial Obligation.</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">The
  information provided in Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 2.03.&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>Item
  3.02</B>&nbsp;<B>Unregistered Sales of Equity Securities.</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">The
  applicable information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 3.02.
  In acquiring the Warrants and the Notes, the Investors made representations to the Company that they met the accredited investor
  definition of Rule 501 of the Securities Act, and the Company relied on such representations. The Warrants and the Notes were
  offered and sold without registration under the Securities Act, in reliance on the exemptions provided by Section 4(a)(2) of the
  Securities Act, as provided in Rule 506 of Regulation D promulgated thereunder, and in reliance on similar exemptions under applicable
  state laws. The offering of the Warrants and the Notes were not conducted in connection with a public offering, and no public
  solicitation or advertisement was made or relied upon by any Investor in connection with the offering. This Current Report on
  Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall such securities be offered or
  sold in the United States absent registration or an applicable exemption from the registration requirements.</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B></B></FONT></P>
  
  <!-- Field: Page; Sequence: 2 -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"></P><P STYLE="margin-top: 0; margin-bottom: 0"></P></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>Item&nbsp;9.01
  Financial Statements and Exhibits</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>&nbsp;</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white"><B>(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits.
  </B>The following exhibits are furnished with this report:</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR>
      <TD COLSPAN="2" STYLE="vertical-align: top; font: 12pt Times New Roman, Times, Serif; background-color: white; padding-right: -40.5pt; text-align: justify; text-decoration: underline; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><U>Exhibit
      No.</U></FONT></TD>
      <TD COLSPAN="3" STYLE="vertical-align: top; font: 12pt Times New Roman, Times, Serif; background-color: white; padding-left: 40.5pt; text-align: justify; text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><U>Exhibit
      Description</U></FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
      <TD STYLE="vertical-align: top; font: 12pt Times New Roman, Times, Serif; background-color: white; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD COLSPAN="3" STYLE="vertical-align: top; font: 12pt Times New Roman, Times, Serif; background-color: white; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD COLSPAN="2" STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD COLSPAN="3" STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">10.1</FONT></TD>
      <TD COLSPAN="3" STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><A HREF="grst8k121916ex10_1.htm">Form of Warrant Agreement (Including the Form of the Warrant and the Warrant Exercise Form), dated December 30, 2016</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD COLSPAN="3" STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">10.2</FONT></TD>
      <TD COLSPAN="3" STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><A HREF="grst8k121916ex10_2.htm">Form of Series L Convertible Note, dated December 30, 2016</A></FONT></TD></TR>
  <TR>
      <TD STYLE="width: 13%">&nbsp;</TD>
      <TD STYLE="width: 5%">&nbsp;</TD>
      <TD STYLE="width: 3%">&nbsp;</TD>
      <TD STYLE="width: 71%">&nbsp;</TD>
      <TD STYLE="width: 5%">&nbsp;</TD>
      <TD STYLE="width: 3%">&nbsp;</TD></TR>
  </TABLE>
  
  <!-- Field: Page; Sequence: 3 -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="background-color: white"><B>SIGNATURES</B></FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <P STYLE="margin: 0; text-align: justify"><FONT STYLE="background-color: white">Pursuant
  to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed
  on its behalf by the undersigned hereunto duly authorized.</FONT></P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">&nbsp;</FONT></P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD COLSPAN="2" STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Date:&nbsp;<B>January
      5,     2017</B></FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-left: 5.4pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">By:</FONT></TD>
      <TD STYLE="border-bottom: black 1pt solid; font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><I>&nbsp;/s/
      Shawn E. Leon</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 72px; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="width: 315px; padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Name:
      Shawn E. Leon</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-left: 5.4pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Title:
      Chief Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font: 12pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-left: 5.4pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  
  <!-- Field: Page; Sequence: 4 -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: white">
      <TD STYLE="width: 14%; font: 12pt Times New Roman, Times, Serif; text-align: left; text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit
      No.</U></FONT></TD>
      <TD STYLE="width: 86%; font: 12pt Times New Roman, Times, Serif; text-align: left; text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Exhibit
      Description</U></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="grst8k121916ex10_1.htm">Form of Warrant Agreement (Including the Form of the Warrant and the Warrant Exercise Form), dated December 30, 2016</A></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
      <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="grst8k121916ex10_2.htm">Form of Series L Convertible Note, dated December 30, 2016</A></FONT></TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>
  
  
  
  <P STYLE="margin: 0"></P>
  
  <!-- Field: Page; Sequence: 5; Options: Last -->
      <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"></P><P STYLE="margin-top: 0; margin-bottom: 0"></P></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin: 0">&#160;</p>
  
  </body>
  </html>
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "grst8k121916.htm", "secsgml_size_bytes": 29776}]
metadata_filer: {"company-data": {"conformed-name": "GREENESTONE HEALTHCARE CORP", "cik": "0000792935", "assigned-sic": "8062", "irs-number": "841227328", "state-of-incorporation": "CO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-15078", "film-number": "17508679"}, "business-address": {"street1": "5734 YONGE ST.", "street2": "SUITE 300", "city": "TORONTO", "state": "A6", "zip": "M2M 4E7", "phone": "416-222-5501"}, "mail-address": {"street1": "5734 YONGE ST.", "street2": "SUITE 300", "city": "TORONTO", "state": "A6", "zip": "M2M 4E7"}, "former-company": {"former-conformed-name": "NOVA NATURAL RESOURCES CORP", "date-changed": "19920703"}}
text: UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  Washington, D.C. 20549
  FORM 8-K
  CURRENT REPORT
  Pursuant to Section 13 or 15(d) of the Securities
  Exchange Act of 1934
  Date of Report (Date of earliest event reported):
  December 30, 2016
  GREENESTONE HEALTHCARE CORPORATION
  (Exact name of registrant as specified in its
  charter)
  Colorado
  000-15078
  84-1227328
  (State
                                           or other jurisdiction of
  incorporation
          or organization)
  (Commission
      File Number)
  (IRS
                                           Employer
  Identification
          No.)
  5734
                                           Yonge Street, Suite 300
  North
          York, Ontario, Canada M2M 4E7
  (Address
      of principal executive offices)
  (416)
      222-5501
  (Registrant's
      telephone number, including area code)
  Check the appropriate box below if the Form
  8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
  [
      ]
  Written
      communications pursuant to Rule 425 under the Securities Act
  [
      ]
  Soliciting
      material pursuant to Rule 14a-12 under the Exchange Act
  [
      ]
  Pre-commencement
      communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  [
      ]
  Pre-commencement
      communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
  Item 1.01
  Entry
  into a Material Definitive Agreement.
  Item
  1.01
  Entry into a Material Definitive Agreement.
  On
  December 19, 2016 GreeneStone Healthcare Corporation, a Colorado corporation (the "Company") closed on a private offering
  (the "Private Offering") to raise USD$500,000.00 in capital. Pursuant to the Private Offering, the Company entered
  into convertible note agreements (the "Series L Convertible Notes" or the "Notes") in exchange for advances
  to the Company of $469,000.00 in total, with certain accredited investors (each an "Investor," and collectively the
  "Investors") and a warrant agreement (the "Warrant Agreement") equal to one Warrant for each dollar of
  Convertible Note issued.
  The
  Convertible Notes and Warrants issued by the Company raised an aggregate principal amount of USD$469,000.00, as follows: (i) the
  Company issued eight Notes for a total of USD$469,000.00 convertible at the option of the Investors into 15,633,333 shares the
  Company's common stock (the "Common Stock"), par value USD$0.01; and (ii) the Company issued 15,633,333 Warrants.
  Unless otherwise provided for in the Notes, the Notes bear a 0% interest rate and mature six months from the date of issuance.
  At any time during the term of each of the Notes, each of the Investors may elect to convert the amount owed under a Note to shares
  of Common Stock of the Company, at a conversion price of USD$0.03 per share of Common Stock. The Warrants entitle each Warrant
  holder to purchase a single share of the Company's Common Stock at an exercise price of USD$0.03 per share for each Warrant
  exercised. The Warrants expire on December 18, 2019.
  The
  Notes and the Warrants were offered and sold without registration under the Securities Act of 1933, as amended (the "Securities
  Act"), in reliance on the exemptions provided by Section 4(a)(2) of the Securities Act, as provided in Rule 506 of Regulation
  D promulgated thereunder. The Warrants and the Notes, and the Common Stock issuable upon exercise of the Warrants and conversion
  of the Notes, have not been registered under the Securities Act, or any other applicable securities laws, and unless so registered
  may not be offered or sold in the United States, except pursuant to an exemption from the registration requirements of the Securities
  Act.
  $249,444.44
  of the proceeds raised in the Private Offering has been used to repay in full certain indebtedness of the Company to JMJ Financial.
  The Company plans to use the balance of the proceeds for its operations.
  The
  foregoing description of the Series L Convertible Notes, Warrant Agreements and the Warrants does not purport to be complete and
  is qualified in its entirety by reference to the forms of the Warrant Agreement (including the form of the Warrant and the Warrant
  exercise form) and the Notes, copies of which are attached hereto as Exhibit 10.1 and Exhibit 10.2 and incorporated herein by
  reference.
  Item
  2.03
  Creation of a Direct Financial Obligation.
  The
  information provided in Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 2.03.
  Item
  3.02
  Unregistered Sales of Equity Securities.
  The
  applicable information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 3.02.
  In acquiring the Warrants and the Notes, the Investors made representations to the Company that they met the accredited investor
  definition of Rule 501 of the Securities Act, and the Company relied on such representations. The Warrants and the Notes were
  offered and sold without registration under the Securities Act, in reliance on the exemptions provided by Section 4(a)(2) of the
  Securities Act, as provided in Rule 506 of Regulation D promulgated thereunder, and in reliance on similar exemptions under applicable
  state laws. The offering of the Warrants and the Notes were not conducted in connection with a public offering, and no public
  solicitation or advertisement was made or relied upon by any Investor in connection with the offering. This Current Report on
  Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall such securities be offered or
  sold in the United States absent registration or an applicable exemption from the registration requirements.
  Item 9.01
  Financial Statements and Exhibits
  (d)       Exhibits.
  The following exhibits are furnished with this report:
  Exhibit
      No.
  Exhibit
      Description
  10.1
  Form of Warrant Agreement (Including the Form of the Warrant and the Warrant Exercise Form), dated December 30, 2016
  10.2
  Form of Series L Convertible Note, dated December 30, 2016
  SIGNATURES
  Pursuant
  to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed
  on its behalf by the undersigned hereunto duly authorized.
  Date:
  January
      5,     2017
  By:
  /s/
      Shawn E. Leon
  Name:
      Shawn E. Leon
  Title:
      Chief Executive Officer
  Exhibit
      No.
  Exhibit
      Description
  10.1
  Form of Warrant Agreement (Including the Form of the Warrant and the Warrant Exercise Form), dated December 30, 2016
  10.2
  Form of Series L Convertible Note, dated December 30, 2016